menu search

APVO / Aptevo to Present at Bio-Europe Conference

Aptevo to Present at Bio-Europe Conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that the Company will present at the upcoming Bio-Europe conference occurring November 6-8, 2023 in Munich, Germany. Details of the Company's presentation, which will highlight its pipeline of clinical and pre-clinical bispecific drug candidates designed to fight both solid and hematologic malignancies, are as follows: Date & Time: Tuesday, November 7, 2023 @ 1:15 CET (8:15 Eastern time) Location: Trade Fair Center Messe München, San Sabastian Room, Munich, Germany Presenter: Michelle Nelson, Ph.D. Read More
Posted: Nov 1 2023, 07:45
Author Name: Accesswire
Views: 091984

APVO News  

Aptevo to Present at Bio-Europe Conference

By Accesswire
November 1, 2023

Aptevo to Present at Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing nov more_horizontal

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

By InvestorPlace
July 30, 2023

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

Millionaire-maker penny stocks, as you might guess from the title does not represent a universally accessible sector. While these ideas can possibly m more_horizontal

Why Did Aptevo Therapeutics Stock Jump 25% Today?

By Benzinga
March 24, 2022

Why Did Aptevo Therapeutics Stock Jump 25% Today?

Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher Thursday after the company reported 2021 financial results.  Aptevo said royalty r more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal

Why Are Aptevo Therapeutics Shares Trading Higher Today?

By Benzinga
February 9, 2022

Why Are Aptevo Therapeutics Shares Trading Higher Today?

Aptevo Therapeutics Inc APVO earned a $10 million non-dilutive milestone payment related to 2021 sales of Ruxience, under the terms of its royalty more_horizontal


Search within

Pages Search Results: